Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randal Hand

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neural Development|August 26, 2011
Neurogenin2 regulates the initial axon guidance of cortical pyramidal neurons projecting medially to the corpus callosumRandal Hand, Franck Polleux
Biorxiv : the Preprint Server for Biology|October 24, 2023
MAP1B Regulates Cortical Neuron Interstitial Axon Branching Through the Tubulin Tyrosination CycleJakub Ziak, Joelle Dorskind, Brian Trigg, et al.
Cell|July 7, 2010
TGF-beta signaling specifies axons during brain developmentJason J Yi, Anthony P Barnes, Randal Hand, et al.
Elife|April 3, 2023
Palmitoylation regulates neuropilin-2 localization and function in cortical neurons and conveys specificity to semaphorin signaling via palmitoyl acyltransferasesEleftheria Koropouli, Qiang Wang, Rebeca Mejías, et al.
Molecular Neurobiology|November 21, 2025
Sigma-2 Receptor Antagonism Enhances the Neuroprotective Effects of Pridopidine, a Sigma-1 Receptor Agonist, in Huntington's DiseaseJing Jin, Randal Hand, May Meltzer, et al.
Science (New York, N.Y.)|November 2, 2013
On and off retinal circuit assembly by divergent molecular mechanismsLu O Sun, Zheng Jiang, Michal Rivlin-Etzion, et al.
Neuron|October 6, 2005
Phosphorylation of Neurogenin2 specifies the migration properties and the dendritic morphology of pyramidal neurons in the neocortexRandal Hand, Dante Bortone, Pierre Mattar, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trialMichal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
Nature Medicine|September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trialRalf Reilmann, Andrew Feigin, Anne E Rosser, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neural Development|August 26, 2011
Neurogenin2 regulates the initial axon guidance of cortical pyramidal neurons projecting medially to the corpus callosumRandal Hand, Franck Polleux
Biorxiv : the Preprint Server for Biology|October 24, 2023
MAP1B Regulates Cortical Neuron Interstitial Axon Branching Through the Tubulin Tyrosination CycleJakub Ziak, Joelle Dorskind, Brian Trigg, et al.
Cell|July 7, 2010
TGF-beta signaling specifies axons during brain developmentJason J Yi, Anthony P Barnes, Randal Hand, et al.
Elife|April 3, 2023
Palmitoylation regulates neuropilin-2 localization and function in cortical neurons and conveys specificity to semaphorin signaling via palmitoyl acyltransferasesEleftheria Koropouli, Qiang Wang, Rebeca Mejías, et al.
Molecular Neurobiology|November 21, 2025
Sigma-2 Receptor Antagonism Enhances the Neuroprotective Effects of Pridopidine, a Sigma-1 Receptor Agonist, in Huntington's DiseaseJing Jin, Randal Hand, May Meltzer, et al.
Science (New York, N.Y.)|November 2, 2013
On and off retinal circuit assembly by divergent molecular mechanismsLu O Sun, Zheng Jiang, Michal Rivlin-Etzion, et al.
Neuron|October 6, 2005
Phosphorylation of Neurogenin2 specifies the migration properties and the dendritic morphology of pyramidal neurons in the neocortexRandal Hand, Dante Bortone, Pierre Mattar, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 17, 2025
Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trialMichal Geva, Y Paul Goldberg, Melanie L Leitner, et al.
Nature Medicine|September 5, 2025
Pridopidine in early-stage manifest Huntington's disease: a phase 3 trialRalf Reilmann, Andrew Feigin, Anne E Rosser, et al.
Pageof 1